How is age-related macular degeneration diagnosed? Which patient is at risk of the disease? What are the treatment options? These, in short, are the questions to which some of the most authoritative have been asked to answerspecialists in ophthalmology, during the webinar recently held within the training course of Floretina 2021, on the topic ‘Neovascular Amd in real life’, chaired by Edoardo Midena, professor of Diseases of the visual apparatus and director of the School of Specialization in Ophthalmology of the University of Padua, and by Stanislao Rizzo, director of the Ophthalmology complex operating unit of the A. Gemelli Irccs University Hospital of Rome, organized with the unconditional contribution of Bayer.
Spread the love